Eisai Lenvima Anticancer Drug approved US indications of Renal Cell Carcinoma
18
May
Recently, Eisai tumor industrial pipelines harvest great news, Lenvima its anti-cancer drug approved by the FDA for the treatment of advanced renal cell carcinoma (renal cell carcinoma, RCC). Last year, Lenvima (lenvatinib mesylate) in the Americas, Europe, Japan, for the … Read More »